UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000028093
Receipt number R000032167
Scientific Title Post-marketing research by HeartSheet patient registration system
Date of disclosure of the study information 2017/07/07
Last modified on 2026/01/20 08:14:11

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Post-marketing research by HeartSheet patient registration system

Acronym

HeartSheet patient registration system

Scientific Title

Post-marketing research by HeartSheet patient registration system

Scientific Title:Acronym

HeartSheet patient registration system

Region

Japan


Condition

Condition

Severe heart failure due to chronic ischemic heart disease

Classification by specialty

Cardiology Cardiovascular surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Characteristics of patients registered in the Heart Seat Patient Registration System (Patient Registration System Regarding Patients Using Heart Sheet etc.), defects / adverse events occurring when using the Heart Sheet, post-marketing data related to the Heart Sheet In the long term and analyze the data to evaluate the effectiveness and safety of the heart sheet.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

1)adverse events
2)Device deficiencies
3) mortality

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients who agreed to participate in this study, among the subjects of HeartSheet Use Results Survey (All Example Studies)

Key exclusion criteria

no reguiation

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Kazuhisa
Middle name
Last name Senshu

Organization

Terumo Corporation

Division name

Clinical Development Department

Zip code

163-1450

Address

Tokyo Opera City Tower 49F, 3-20-2, Nishi-Shinjuku, Shinjuku-ku, Tokyo, Japan

TEL

03-6742-8500

Email

Rinshokenkyu_HS@terumo.co.jp


Public contact

Name of contact person

1st name kazuo
Middle name
Last name tamada

Organization

Terumo Corporation

Division name

Clinical Development Department

Zip code

163-1450

Address

Tokyo Opera City Tower 49F, 3-20-2, Nishi-Shinjuku, Shinjuku-ku, Tokyo, Japan

TEL

03-6742-8500

Homepage URL


Email

Rinshokenkyu_HS@terumo.co.jp


Sponsor or person

Institute

Terumo Corporation

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Review Board

Address

1500, inokuchi,nakaimachi,ashigarakami-gun kanagawa, Japan

Tel

0465-81-4112

Email

Hirokazu_Hasegawa@terumo.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 07 Month 07 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

29

Results

Of the target patients, 29 cases consented to participate in this study. Data for 26 of these cases was transferred to the database for this study. (The data for the remaining 3 cases had not been fixed in the HeartSheet PMS, which was the subject of the study, at the end of this study, so they were not transferred to the database for this study.) Study results are currently being compiled.

Results date posted

2026 Year 01 Month 19 Day

Results Delayed

Delay expected

Results Delay Reason

Study results are currently being compiled.

Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 12 Month 12 Day

Date of IRB

2016 Year 10 Month 05 Day

Anticipated trial start date

2017 Year 10 Month 01 Day

Last follow-up date

2023 Year 09 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

None


Management information

Registered date

2017 Year 07 Month 06 Day

Last modified on

2026 Year 01 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000032167